In patients with AD, an abnormal increase in acetylcholinesterase (AChE) activity can increase the velocity of ACh catabolism, resulting in a lower level of ACh in the brain and consequently affecting the transmission of nerve impulses in the central nervous system. Here, ACHE is linked to Alzheimer disease.